Exchange of C-Terminal Variable Sequences within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) against PPR. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/v13112320
PubMed Identifier: 34835126
Publication URI: http://europepmc.org/abstract/MED/34835126
Type: Journal Article/Review
Volume: 13
Parent Publication: Viruses
Issue: 11
ISSN: 1999-4915